BioSpace News Archive

Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that the management team will participate in the Sidoti Small Cap Virtual Conference on Thursday, September 24, 2020.

Verastem, Inc., a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, announced that management will present virtually at the following upcoming investor conferences

Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in a virtual fireside chat at the Cantor Global Healthcare Conference at 4:40 p.m. ET on Wednesday, September 16, 2020.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference

Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, September 21, 2020 to discuss the company’s presentations at the 2020 European Society for Medical Oncology (ESMO) Virtual Congress.

BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer, will participate in the following upcoming investor conferences.

Universal Health Services, Inc. (NYSE: UHS) today announced the pricing of its previously announced private offering of senior secured notes due 2030.

Agreement expands patient access to SINUVA treatment with announcement of third partnership with a specialty pharmacy

The American Association of Kidney Patients (AAKP) announced results of their recent 2020-2021 Board Officers and Directors elections. Founded in 1969, AAKP is the oldest and largest fully independent kidney organization in the United States, with a majority patient-lead Board.

Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has priced its previously announced underwritten public offering of 10,000,000 common shares (the “Common Shares”) of the Company (the “Offering”).